J. McBride

Acanthamoeba alternative oxidase genes: identification, characterisation and potential as antimicrobial targets.

F. Roberts, C. Roberts, F. Henriquez, 2009, International journal for parasitology.

Analytical and clinical performance characteristics of Hybritech's Tandem-R free PSA assay during a large multicenter clinical trial to determine the clinical utility of percentage of free prostate-specific antigen.

D. Chan, J. Beck, D. Lamb, 1999, Clinical chemistry.

Multifunctional nanobeacon for imaging Thomsen‐Friedenreich antigen‐associated colorectal cancer

J. Gore, M. Kataoka, S. Sakuma, 2013, International journal of cancer.

Implementation, adherence, and results of systematic SARS-CoV-2 testing for asymptomatic patients treated at a tertiary care regional radiation oncology network

S. Burri, C. Corso, D. Raghavan, 2021, Radiation oncology.

Development of Colorimetric Microtiter Plate Assay for Assessment of Antimicrobials against Acanthamoeba

C. Roberts, F. Henriquez, P. Ingram, 2005, Journal of Clinical Microbiology.

Differential cytotoxicity of phospholipid analogues to pathogenic Acanthamoeba species and mammalian cells.

C. Roberts, A. Mullen, K. Carter, 2007, The Journal of antimicrobial chemotherapy.

Suramin in hormone-refractory metastatic prostate cancer: a drug with limited efficacy.

A. Belldegrun, E. Landaw, J. Dekernion, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic and predictive biomarkers in patients with COVID-19 treated with tocilizumab in a randomised controlled trial

K. Blyth, C. H. van der Leest, N. Rohatgi, 2020, medRxiv.

Long-term NSAID use in primary care: changes over a decade and NICE risk factors for gastrointestinal adverse events.

J. McBride, P. Thompson, L. Tee, 2005, Rheumatology.

Acanthamoeba alternative oxidase genes: identification, characterisation and potential as antimicrobial targets.

F. Roberts, C. Roberts, F. Henriquez, 2009, International Journal of Parasitology.